Supercharging drug development through AI
July 13, 2022
How much faster can we identify potential lifesaving medications for diseases such as COVID-19?
UBC’s Dr. Artem Cherkasov has discovered the answer to that question: “Instead of 10 years, it took us 19 days. We screened 40 billion potential drug compounds and narrowed those down to a shortlist of a handful of highly promising candidates,” he says.
Dr. Cherkasov and his team have developed Deep Docking, an AI-enabled technology that identifies previously unknown potential medications for people already infected with the virus.
- Research
- Feature story